CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Novartis AG

NVS
$271.55BMega Cap

Next catalyst

Phase 3October 2026

Ianalumab

Warm Autoimmune Hemolytic Anemia (wAIHA)

Source

Get an email about NVS's next catalysts

Track Novartis (NVS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 57 more upcoming events in our data (Phase 3 readout, Phase 2 readout, NDA filing).See the timeline

Catalyst Timeline

59 upcoming, 7 past

Earnings
✓Positive

NVS Earnings Report

Oct 27, 2026

EPS Est: $2.25 | FQ end Sep/2026 | Call: bmo

Novartis raised its annual profit outlook following strong Q3 sales growth.

Phase 3Next

ianalumab Phase 3 Est. Readout

October 2026~Ianalumab226

Primary completion for ianalumab trial (NCT05624749) in Systemic Lupus Erythematosus

Source
Phase 3

LOU064 (blinded) Phase 3 Est. Readout

November 2026~LOU064 (blinded)100

Primary completion for LOU064 (blinded) trial (NCT05677451) in Chronic Spontaneous Urticaria

Source
Phase 2

177Lu-PSMA-617 Phase 2 Est. Readout

December 2026~177Lu-PSMA-61724

Estimated primary completion for 177Lu-PSMA-617 trial (NCT06964958) in Renal Cell Carcinoma. Topline data typically follows completion by weeks to months.

Source
Phase 2

AAA617 Phase 2 Est. Readout

December 2026~68Ga-PSMA-1123

Estimated primary completion for AAA617 trial (NCT06004661) in Metastatic Castration-Resistant Prostate Cancer (mCRPC). Topline data typically follows completion by weeks to months.

Source
Phase 2

AAA517 Phase 2 Est. Readout (PSMACare)

December 2026~AAA51749

Estimated primary completion for AAA517 trial (NCT05849298) in Prostatic Neoplasm. Topline data typically follows completion by weeks to months.

Source
Phase 2

Iptacopan Phase 2 Est. Readout

December 2026~Iptacopan84

Primary completion for Iptacopan trial (NCT06388941) in Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis

Source
Phase 2

Lutetium Lu 177 Vipivotide Tetraxetan Phase 2 Est. Readout

December 2026~Lutetium Lu 177 Vipivotide Tetraxetan15

Estimated primary completion for Lutetium Lu 177 Vipivotide Tetraxetan trial (NCT06145633) in Castration-Resistant Prostate Carcinoma. Topline data typically follows completion by weeks to months.

Source

How NVS's past catalysts played out

Phase 3 readoutFeb 2026-1%Phase 3 readoutFeb 2026+1%Phase 3 readoutJan 2026+1%PDUFA decisionOct 2019-1%PDUFA decisionMay 2019+0%

Market Overview

Stock performance and key metrics

NYSEPharmaceutical PreparationsPharmaceuticals🇺🇸EuropeBASEL75.9K employees

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.

Website
Drug Pipeline

Inclisiran Sodium for injection

Phase 3

Homozygous Familial Hypercholesterolemia

Certican®

Phase 3

Renal Interstitial Fibrosis

Verteporfin PDT

Phase 3

Pathological Myopia

cTIV or eTIV_a

Phase 3

Influenza

ABL001

Phase 3

Chronic Myelogenous Leukemia - Chronic Phase

Tetanus toxoid polysaccharide-conjugated vaccine against Haemophilus influenzae type b (Hib)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

2a - Routine and rMenB+OMV NZ vaccines

Phase 3

Meningococcal Disease

3a - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

4a- rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

1b - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

2b - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

3b - 1 dose of rMenB+OMV NZ plus routine infant vaccinations

Phase 3

Meningococcal Disease

4b - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

MF59-adjuvanted trivalent influenza vaccine (aTIV)

Phase 3

Influenza Disease

Canakinumab (ACZ885)

Phase 3

Cryopyrin-Associated Periodic Syndromes

Secukinumab/Adalimumab-Biosimilar

Phase 3

Axial Spondyloarthritis

standard therapy

Phase 3

Lung Transplantation

Ofatumumab approved dose

Phase 3

Relapsing Multiple Sclerosis (RMS)

Somatostatin (octreotide)

Phase 3

Carcinoma, Hepatocellular

LAF237 = vildagliptin

Phase 3

Diabetes Mellitus, Non-Insulin-Dependent

Octreotide Long Acting Release

Phase 3

Chemotherapy-induced Diarrhea

JDQ443

Phase 3

Non-Small Cell Lung Cancer

RTH258/Brolucizumab

Phase 3

Neovascular Age-Related Macular Degeneration

Telbivudine (LdT)

Phase 3

Chronic Hepatitis B

Lumiracoxib (drug)

Phase 3

Osteoarthritis, Hip

Recombinant meningococcal B + OMV NZ

Phase 3

Meningococcal Disease

ACZ885

Phase 3

TNF-receptor Associated Periodic Syndromes (TRAPS)

Lansoprazole

Phase 3

Heartburn

Meningococcal ACWY conjugate vaccine

Phase 3

Bacterial Meningitis

Seasonal Influenza Vaccine

Phase 3

Influenza

Inclisiran

Phase 3

Familial Hypercholesterolemia - Homozygous

Prograf or Neoral

Phase 3

Kidney Transplantation

Pandemic influenza vaccine

Phase 3

Influenza

rMenB+OMV-NZ

Phase 3

Meningococcal Disease

IPV (Inactivated Polio Vaccine) Vaccine

Phase 3

Meningitis

albumin interferon alfa-2b

Phase 3

Chronic Hepatitis C

Octreotide acetate

Phase 3

Acromegaly

IVIG infusion

Phase 3

Immune Thrombocytopenic Purpura

Xylometazoline

Phase 3

Common Cold

Cell-Derived Trivalent Subunit Influenza Vaccine Lot 2 (cTIV)

Phase 3

Influenza

MMR (Measles, Mumps, and Rubella) Vaccine

Phase 3

Meningitis

Meningococcal ACWY Polysaccharide Vaccine

Phase 3

Meningococcal Meningitis

Acetaminophen and Aspirin

Phase 3

Acute Migraine

Mycophenolate acid (MPA)/Azathioprine (AZA)

Phase 3

Liver Transplantation

Cell-Derived Trivalent Subunit Influenza Vaccine Lot 3 (cTIV)

Phase 3

Influenza

lapatinib ditosylate

Phase 3

Breast Cancer

DTaP (Diptheria, Tetanus, Pertussis) Vaccine

Phase 3

Meningitis

Hib (Haemophilus influenza b) Vaccine

Phase 3

Meningitis

Hepatitis A Virus

Phase 3

Meningitis

Bosutinib

Phase 3

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

Rivastigmine 5 cm^2

Phase 3

Alzheimer Disease

Pneumococcal conjugate Vaccine

Phase 3

Meningitis

Eculizumab

Phase 3

Paroxysmal Nocturnal Hemoglobinuria (PNH)

zigakibart

Phase 3

Immunoglobulin A Nephropathy (IgAN)

Enteric-coated Mycophenolate Sodium

Phase 3

Autoimmune Disease

oxcarbazepine

Phase 3

Epilepsy

Trametinib

Phase 3

Cancer

Omalizumab

Phase 3

Asthma

Adjuvanted monovalent influenza virus vaccine (aH5N1)

Phase 3

Pandemic Influenza Disease

Minimisation of TAC

Phase 3

Liver Transplant

LCZ

Phase 3

Hypertension

Abatacept

Phase 3

Rheumatoid Arthritis

Mycophenolate Sodium Delayed Release Tablets

Phase 3

End Stage Renal Disease

amlodipine/benazepril

Phase 3

Hypertension

Canakinumab pre-filled syringe

Phase 3

Acute Gouty Arthritis

Mycophenolate sodium

Phase 3

Kidney Transplantation

Canakinumab (AIN457)

Phase 3

Periodic Fevers Syndrome

EPO906 (Patupilone)

Phase 3

Ovarian Cancer

Best Available Therapy (BAT)

Phase 3

Myelofibrosis

valsartan/amlodipine

Phase 3

Hypertension

Ofatumumab subcutaneous injection

Phase 3

Relapsing Multiple Sclerosis

Enteric-coated mycophenolate sodium (EC-MPS)

Phase 3

Renal Transplantation

DTwP-HepB-Hib Vaccine

Phase 3

Diphtheria

Ritalin LA

Phase 3

Attention Deficit/Hyperactivity Disorder

LNP023

Phase 3

IgA Nephropathy

Trivalent influenza virus vaccine (TIV)

Phase 3

Pandemic Influenza Disease

Ruxolitinib

Phase 3

Primary Myelofibrosis (MF)

Ali/Amlo

Phase 3

Essential Hypertension

Tiotropium

Phase 3

Chronic Obstructive Pulmonary Disease

Lapatinib

Phase 3

Neoplasms, Breast

Fumaric acid

Phase 3

Psoriasis

MenACWY-CRM

Phase 3

Meningococcal Infections

QAW039

Phase 3

Asthma

diclofenac diethylamine

Phase 3

Grade I/II Ankle Sprain

Cell culture-derived influenza subunit vaccine (cTIV)

Phase 3

Influenza

Entecavir

Phase 3

Hepatitis B

Certoparin

Phase 3

Persistent Nonvalvular Atrial Fibrillation

Secukinumab, s.c

Phase 3

Giant Cell Arteritis

Olmesartan

Phase 3

Essential Hypertension

Fingolimod

Phase 3

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Ceritinib

Phase 3

ALK-positive Non-small Cell Lung Cancer

Monovalent A/H1N1 influenza vaccine

Phase 3

Pandemic Influenza

Terbinafine hydrochloride (HCl)

Phase 3

Tinea Capitis

MenACWY-CRM197 (two doses)

Phase 3

Meningococcal Meningitis

Iptacopan (LNP023)

Phase 3

Paroxysmal Nocturnal Hemoglobinuria (PNH)

MenACWY-CRM conjugate vaccine

Phase 3

Meningococcal Meningitis

Cell culture-derived influenza vaccine

Phase 3

Influenza

Licarbazepine

Phase 3

Bipolar I Disorder

Aliskiren

Phase 3

Hypertension

Pelacarsen (TQJ230)

Phase 3

Atherosclerotic Cardiovascular Disease

Secukinumab

Phase 3

Psoriatic Arthritis

AIN457

Phase 3

Behcet Disease

AAA617

Phase 3

Oligometastatic Prostate Cancer (OMPC)

[18F]CTT1057

Phase 3

Prostatic Neoplasms

ranibizumab

Phase 3

Choroidal Neovascularization

TIV1c

Phase 3

Influenza

NVA237

Phase 3

Chronic Obstructive Pulmonary Disease

Valsartan

Phase 3

Hypertension

cyclosporine

Phase 3

de Novo Kidney Transplant Recipients

Octreotide LAR

Phase 3

Somatostatin Receptor Positive (SSTR+)

Zoledronic acid

Phase 3

Cancer Prostate

QVA149

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Bexsero® vaccine (1 dose at study month zero)

Phase 3

Meningoccocal Disease

Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)

Phase 3

N. Meningitidis Carriage

DTaP-IPV-HBV

Phase 3

Meningitis, Meningococcal

tisagenlecleucel

Phase 3

Follicular Lymphoma

Focalin XR

Phase 3

ADHD

Brolucizumab

Phase 3

Diabetic Macular Edema

BYM338/bimagrumab

Phase 3

Sporadic Inclusion Body Myositis

Sulfadoxine pyrimethamine

Phase 3

Malaria in Pregnancy

Vildagliptin

Phase 3

Diabetes Mellitus, Type 2

MF59-eH1N1_f

Phase 3

Influenza

DTaP-IPV/Hib

Phase 3

Meningococcal Disease

Ianalumab

Phase 3

Warm Autoimmune Hemolytic Anemia (wAIHA)

Artemether-lumefantrine

Phase 3

Malaria

FTY720

Phase 3

Renal Transplantation

Depiquick Birch (DPG103)

Phase 3

Allergic Rhinoconjunctivitis

MenACWY CRM

Phase 3

Meningococcal Infections

Influenza vaccine

Phase 3

Influenza

Indacaterol

Phase 3

Chronic Obstructive Pulmonary Disease

agomelatine

Phase 3

Major Depressive Disorder

rMenB + OMV NZ vaccine

Phase 3

Meningococcal Disease

Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Fevipiprant

Phase 3

Nasal Polyps

LMF237

Phase 3

Diabetes Mellitus, Type 2

Tetanus toxoid vaccine

Phase 3

Relapsing Multiple Sclerosis

Ritalin LA (methylphenidate hydrochloride extended release)

Phase 3

Attention Deficit/Hyperactivity Disorder

Tifacogin

Phase 3

Pneumonia

Calcineurin inhibitors (CNI)

Phase 3

Liver Transplantation

indacaterol and glycopyrronium bromide (QVA149)

Phase 3

COPD

Tacrolimus (reduced tacrolimus)

Phase 3

Liver Transplant Recipient

Hydrochlorothiazide (HCTZ)

Phase 3

Essential Hypertension

Mitomycin (MMC)

Phase 3

Glaucoma

Votoplam (blinded)

Phase 3

Huntington Disease

recombinant interferon alfa

Phase 3

Leukemia

eltrombopag

Phase 3

Thrombocytopaenia

Cyclosporine A microemulsion

Phase 3

Chronic Plaque Psoriasis

TIVc_LOT A

Phase 3

Prophylaxis: Influenza

Diclofenac Sodium Gel

Phase 3

Osteoarthritis of the Knee

Teriflunomide

Phase 3

Relapsing Multiple Sclerosis

valsartan+amlodipine combination, valsartan, amlodipine

Phase 3

Hypertension

1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningococcal Disease

Capmatinib

Phase 3

Carcinoma, Non-Small-Cell Lung

RTH258

Phase 3

Neovascular Age Related Macular Degeneration

OFC Infusion

Phase 3

Leukaemia, Lymphocytic, Chronic

rabies vaccine

Phase 3

Rabies Post-exposure Prophylaxis

Cell derived subunit trivalent nonadjuvanted vaccine

Phase 3

Influenza

irbesartan

Phase 3

Hypertension

Enteric-coated Mycophenolate sodium (EC-MPS), valsartan

Phase 3

De Novo Renal Transplantation

EC-MPS

Phase 3

Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS

Ruxolitinib (RUX)

Phase 3

Corticosteroid Refractory Acute Graft vs Host Disease

Iptcaopan

Phase 3

Atypical Hemolytic Uremic Syndrome

Labeled regime arm

Phase 3

Diabetic Macular Edema

Long-acting beta 2-agonist (LABA)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Valsartan + Amlodipine besilate

Phase 3

Hypertension

Mycophenolic Acid (MPA)

Phase 3

Kidney Transplantation

First line DMT

Phase 3

Multiple Sclerosis

Meningococcal B Recombinant vaccine rMenB+OMV NZ

Phase 3

Meningococcal Disease

Everolimus and tacrolimus

Phase 3

Kidney Transplant

Risedronate

Phase 3

Paget's Disease of Bone

Daptomycin

Phase 3

Infections

Salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

sacubitril/valsartan

Phase 3

Heart Failure With Preserved Ejection Fraction

Octreotide

Phase 3

Thymoma

Enalapril

Phase 3

Pediatric Heart Failure

NVA237 and indacaterol

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

ciclosporin

Phase 3

Severe Atopic Dermatitis

rofecoxib

Phase 3

Osteoarthritis

sulfonylurea (SU)

Phase 3

Type 2 Diabetes Mellitus (T2DM)

MF59-eH1N1

Phase 3

Influenza

MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)

Phase 3

Influenza

basiliximab

Phase 3

Liver Transplantation

valsartan+amlodipine combination

Phase 3

Hypertension

Telbivudine

Phase 3

Hepatitis B Virus

Depigoid

Phase 3

Allergic Asthma

Anti R-IL2 + Cyclosporine

Phase 3

Renal Transplant

Lidocaine + CPC

Phase 3

Sore Throat Due to a Common Cold

onasemnogene abeparvovec

Phase 3

Spinal Muscular Atrophy (SMA)

FTY720 + reduced-dose Neoral (RDN) + corticosteroids

Phase 3

Kidney Transplantation

Ofatumumab

Phase 3

Relapsing Multiple Sclerosis

Deferasirox

Phase 3

Beta-thalassemia

canakinumab

Phase 3

NALP3 Mutation

Interferon beta-1a

Phase 3

Multiple Sclerosis

ACZ885 (Canakinumab)

Phase 3

Systemic Juvenile Idiopathic Arthritis (SJIA)

IFF flavor 316 282, Paracetamol, Phenylephrine, Guaifenesin

Phase 3

Upper Respiratory Infections

Candesartan+HCTZ - Phase 1

Phase 3

Hypertension

TRI476

Phase 3

Partial Onset Seizures

Ansastrozole

Phase 3

Early Breast Cancer

Aliskiren/amlodipine

Phase 3

Moderate to Severe Hypertension

Pasireotide (SOM230)

Phase 3

Carcinoid Tumors

Verteporfin photodynamic therapy

Phase 3

Macular Degeneration

Glycopyrronium bromide

Phase 3

Chronic Obstructive Pulmonary Disease

IFF flavor 316 282, Paracetamol, Pseudoephedrine

Phase 3

Upper Respiratory Infections

LOU064 (b.i.d)

Phase 3

Chronic Spontaneous Urticaria

Fluvastatin

Phase 3

Heterozygous Familial Hypercholesterolemia

Tobramycin Solution for Inhalation

Phase 3

Cystic Fibrosis

indacaterol and glycopyrronium (QVA149)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Certican

Phase 3

Kidney Transplantation

Artemether-lumefantrine (COA566)

Phase 3

Acute Uncomplicated Falciparum Malaria

Pasireotide LAR

Phase 3

Acromegaly

Rivastigmine capsule

Phase 3

Parkinson's Disease Dementia

Vildagliptin AM

Phase 3

Diabetes Mellitus, Type 2

Cyclosporine/cyclosporine microemulsion

Phase 3

Liver Transplantation

Indacaterol acetate/Mometasone furoate

Phase 3

Asthma

glycopyrronium (NVA237)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

panobinostat

Phase 3

Relapsed and Bortezomib Refractory Multiple Myeloma

CTL019

Phase 3

B-cell Acute Lymphoblastic Leukemia

Rivastigmine 5 cm^2 transdermal patch

Phase 3

Alzheimer's Disease

Diclofenac sodium topical

Phase 3

Ankle Sprain

interferon-alpha (INF-a)

Phase 3

Chronic Myelogenous Leukemia

RLX030

Phase 3

Chronic Heart Failure (CHF)

Secukinumab (AIN457)

Phase 3

Psoriatic Arthritis

HCQ

Phase 3

Covid-19

Tegaserod

Phase 3

Heartburn

Haemophilus influenzae type b (Hib) vaccine

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine

Phase 3

Meningococcal Meningitis

ICL670

Phase 3

Transfusional Iron Overload

MenACWY-CRM + MMRV

Phase 3

Meningococcal Infections

QIVc

Phase 3

Influenza

Lumiracoxib

Phase 3

Osteoarthritis

eH1N1_f

Phase 3

Novel 2009 Influenza H1N1

Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Cell culture derived seasonal trivalent influenza vaccine (cTIV)

Phase 3

Influenza

cTIV

Phase 3

Seasonal Influenza Vaccine

etanercept

Phase 3

Chronic Plaque Psoriasis

TQJ230

Phase 3

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Dexmethylphenidate HCl extended-release capsules

Phase 3

ADHD, ADD

Trivalent split influenza vaccine (TIV)

Phase 3

Influenza Disease

preservative free inactivated split influenza vaccine using the strain composition 2006/2007

Phase 3

Influenza

LCZ696

Phase 3

Heart Failure

rMenB+OMV NZ

Phase 3

Meningococcal Disease

TIVc

Phase 3

Human Influenza

Rabies vaccines + Rabies immunoglobulins

Phase 3

Rabies Infection

Meningococcal ACWY conjugate vaccine (MenACWY-CRM)

Phase 3

Meningococcal Disease

onasemnogene abeparvovec-xioi

Phase 3

Spinal Muscular Atrophy

No Vaccine

Phase 3

Meningococcal Disease

Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011

Phase 3

Seasonal Influenza

Novartis MenACWY-CRM

Phase 3

Meningococcal Disease

MenACWY-CRM Vaccine

Phase 3

Prevention of Meningococcal Disease

Rivastigmine Transdermal Patch

Phase 3

Alzheimer's Disease

Zagreb

Phase 3

Rabies

Haemophilus influenzae type b vaccine

Phase 3

Haemophilus Influenzae Type b

Lot A of Influenza virus vaccine

Phase 3

Influenza

Routine Vaccines

Phase 3

Meningococcal Disease

LOU064

Phase 3

Chronic Spontaneous Urticaria

QMF149

Phase 3

Asthma

FTY 720

Phase 3

Kidney Transplantation

Lamivudine

Phase 3

Hepatitis

TIVf

Phase 3

Human Influenza

Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine

Phase 3

Influenza

AAA817

Phase 3

Prostate Cancer

Hib-CRM197

Phase 3

Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b

Investigators choice of SoC

Phase 3

Prostate Cancer

Triamcinolone acetonide

Phase 3

Acute Gout

Olmesartan medoxomil

Phase 3

Hypertension

trivalent split influenza vaccine

Phase 3

Seasonal Influenza

177Lu-PSMA-617

Phase 3

Prostatic Neoplasms

AIN457 (secukinumab)

Phase 3

Psoriatic Arthritis

Inclisiran Sodium

Phase 3

ASCVD

Introduction of everolimus with reduced cyclosporine or tacrolimus dose, the earliest 1 month and the latest 6 months after liver transplantation

Phase 3

Renal Function

Everolimus

Phase 3

Islet Cell Carcinoma

Aliskiren/HCTZ

Phase 3

Hypertension

eltrombopag olamine (SB-497115-GR)

Phase 3

Purpura, Thrombocytopaenic, Idiopathic

Imatinib mesilate

Phase 3

Refractory Desmoplastic Small Round Cell Tumors

Agomelatine (AGO178C)

Phase 3

Major Depressive Disorder

Canakinumab in prefilled syringe

Phase 3

Acute Gouty Arthritis

Iptacopan

Phase 3

Glomerulonephritis, IGA

Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Relapsing Multiple Sclerosis

Adjuvanted influenza vaccine

Phase 3

Influenza Disease

Secukinumab provided in pre-filled syringes (PFSs) for injection

Phase 3

Ankylosing Spondylitis

Meningococcal ACWY-CRM conjugate vaccine

Phase 3

Meningococcal Disease

BEGRIVAC

Phase 3

Seasonal Influenza

1a - rMenB+OMV NZ and routine vaccines

Phase 3

Meningococcal Disease

formoterol

Phase 3

Asthma

Influenza Virus Vaccine

Phase 3

Influenza Disease; Flu

Adjuvanted seasonal influenza vaccine

Phase 3

Influenza

Alpelisib

Phase 3

Advanced Breast Cancer

Trivalent influenza virus vaccine (TIVf)

Phase 3

Human

AMN107

Phase 3

Gastrointestinal Stromal Tumors

Ocrelizumab

Phase 3

Relapsing Multiple Sclerosis

Salmeterol/fluticasone

Phase 3

Chronic Obstructive Pulmonary Disease

Terbinafine

Phase 3

Tinea Pedis

CDZ173

Phase 3

Common Variable Immunodeficiency (CVID), APDS / PASLI

Everolimus (RAD001)

Phase 3

Tuberous Sclerosis Complex (TSC)

Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy

Phase 3

Non-Hodgkin Lymphoma

dovitinib

Phase 3

Hepatocellular Carcinoma

Bimagrumab

Phase 3

Sporadic Inclusion Body Myositis

Meningococcal C conjugate vaccine

Phase 3

Prevention of Meningococcal Infection

Cell culture-derived trivalent subunit influenza vaccine (cTIV)

Phase 3

Influenza

Everolimus + reduced tacrolimus

Phase 3

Liver Transplantation

Hydroxycarbamide

Phase 3

Polycythemia Vera

Mycophenolate sodium (enteric coated)

Phase 3

Renal Transplant

Diclofenac potassium

Phase 3

Post Operative Dental Pain

valsartan+amlodipine

Phase 3

Hypertension

canakinumab (company code: ACZ885D)

Phase 3

Cryopyrin Associated Periodic Syndrome

Siponimod

Phase 3

Multiple Sclerosis

Everolimus + Cyclosporine

Phase 3

Renal Transplantation

serogroup B meningococcal vaccine

Phase 3

Meningococcal Disease

Darifenacin

Phase 3

Overactive Bladder Syndrome

Umeclidinium/vilanterol

Phase 3

Chronic Obstructive Pulmonary Disease

TOBI

Phase 3

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

telbivudine or lamivudine

Phase 3

Chronic Hepatitis B

rMenB+OMV NZ with routine vaccinations

Phase 3

Meningococcal Disease

Aromatase Inhibitor

Phase 3

Neoplasms, Breast

Typhoid Vi Polysaccharide Vaccine

Phase 3

Meningococcal Disease

vildagliptin + metformin

Phase 3

Diabetes Mellitus, Type 2

Adjuvanted trivalent inactivated subunit influenza vaccine

Phase 3

Influenza, Human

Osilodrostat

Phase 3

Cushing's Syndrome

Secukinumab auto-injector

Phase 3

Plaque Psoriasis

BAF312

Phase 3

Secondary Progressive Multiple Sclerosis

Terbinafine hydrochloride

Phase 3

Tinea Capitis

Cyclosporine (Neoral)

Phase 3

Organ Transplantation, Renal Transplantation

Methylphenidate long-acting

Phase 3

Attention Deficit Hyperactivity Disorder

paroxetine

Phase 3

Major Depressive Disorder

terbinafine hydrogen chloride

Phase 3

Onychomycosis

Ianalumab (VAY736)

Phase 3

Sjogrens Syndrome

Teriparatide

Phase 3

Osteoporosis

Myfortic

Phase 3

Kidney Transplantation

rMenB+OMV

Phase 3

Healthy

Vatalanib

Phase 3

Colorectal Neoplasms

Rivastigmine Patch

Phase 3

Alzheimer's Disease

Abbreviated Zagreb 2-1-1 schedule

Phase 3

Rabies

Physicians' Choice

Phase 3

Leukaemia

QAB149

Phase 3

COPD

valsartan + simvastatin

Phase 3

HYPERTENSION

Ranibizumab - 3 times monthly, then quarterly

Phase 3

Age Related Macular Degeneration

NVA237 (glycopyrronium bromide)

Phase 3

Asthma

Erenumab

Phase 3

Migraine

Secukinumab s.c

Phase 3

Plaque Psoriasis

imatinib mesylate

Phase 3

Leukemia

Diclofenac sodium

Phase 3

Acute Blunt Soft Tissue Injuries/Contusions

Long-acting beta2-agonist

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Paracetamol/dimethindene maleate/phenylephrine hydrochloride

Phase 3

Upper Respiratory Tract Infection

Lapatinib (GW572016) oral tablets

Phase 3

Neoplasms, Breast

QTI571

Phase 3

Severe Pulmonary Arterial Hypertension

68Ga-PSMA-11

Phase 3

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Ranibizumab (RFB002)

Phase 3

Diabetic Macular Edema

Valsartan + nateglinide

Phase 3

Diabetes Mellitus, Type 2

brolucuzumab IVT

Phase 3

Age-Related Macular Degeneration

AMG334 Pre-Filled Syringe (PFS)

Phase 3

Episodic Migraine

BYM338 (Bimagrumab)

Phase 3

Sporadic Inclusion Body Myositis (sIBM)

ARDT

Phase 3

Prostatic Neoplasms

oral adefovir

Phase 3

Hepatitis B, Chronic

SBR759A

Phase 3

Hyperphosphatemia

diclofenac diethylamine, DDEA

Phase 3

Osteoarthritis, Knee

Novartis Meningococcal ACWY Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Atenolol

Phase 3

Hypertension

Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningitis, Meningococcal, Serogroup B

Clozapine

Phase 3

Schizophrenia

indacaterol maleate

Phase 3

Asthma

Androgen Deprivation Therapy (ADT)

Phase 3

Prostate Cancer

Lymphodepleting chemotherapy

Phase 3

Diffuse Large B-cell Lymphoma (DLBCL)

Pasireotide

Phase 3

Cushing Disease

Diclofenac Topical Sodium

Phase 3

Osteoarthritis

ianalumab s.c. q4w

Phase 3

Lupus Nephritis

Crizanlizumab

Phase 3

Sickle Cell Disease

Best Available Therapy

Phase 3

Polycythemia Vera

basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)

Phase 3

Pediatric Kidney Transplantation

Valsartan and simvastatin

Phase 3

Hypertension

Pelacarsen (TQJ230) s.c

Phase 3

Hyperlipoproteinemia(a)

LOU064 (open-label)

Phase 3

Chronic Spontaneous Urticaria

[68Ga]Ga-DOTA-TATE

Phase 3

Neuroendocrine Neoplasms

asciminib

Phase 3

Leukemia, Chronic Myelogenous

Ciprofloxacin (BAYQ3939) dry powder for inhalation

Phase 3

Bronchiectasis

NIS793

Phase 3

Metastatic Pancreatic Ductal Adenocarcinoma

Nilotinib

Phase 3

Leukemia

BION-1301

Phase 3

IgA Nephropathy

LCQ908

Phase 3

Non-alcoholic Fatty Liver Disease (NAFLD)

Everolimus (Certican)

Phase 3

Heart Transplantation

Cell-Derived Trivalent Subunit Influenza Vaccine Lot 1 (cTIV)

Phase 3

Influenza

Octreotide Acetate in Microspheres

Phase 3

Diabetic Retinopathy

Heparin

Phase 3

Embolism

exemestane

Phase 3

Post Menopausal Breast Cancer

Amlodipine

Phase 3

Hypertension; Hypertrophy, Left Ventricular

Pazopanib

Phase 3

Ovarian Cancer

[F-18]PBR06

Phase 3

Relapsing Multiple Sclerosis

Letrozole

Phase 3

Breast Cancer

tamoxifen

Phase 3

Breast Cancer

LAF 237

Phase 3

Type 2 Diabetes Mellitus

Imatinib

Phase 3

Chronic Myeloid Leukemia

Omalizumab (Xolair)

Phase 3

Steroid and/or Prednisone Dependent Asthma

Multi-Allergen Oral Immunotherapy

Phase 3

Peanut Allergy

Bexsero®

Phase 3

Meningococcal Disease

Valsartan + Hydrochlorothiazide

Phase 3

Hypertension

Imatinib and Nilotinib

Phase 3

Leukemia, Myeloid, Chronic, BCR-ABL Positive

Aclasta

Phase 3

Prevention of BMD Loss After THR

Cyclosporin A

Phase 3

Kidney Transplantation

Novartis Investigational H5N1 vaccine

Phase 3

Influenza, Human

Goserelin

Phase 3

Advanced Metastatic Breast Cancer

Rivastigmine prevention of delirium

Phase 3

Delirium

capsules containing: carbidopa, levodopa, entacapone

Phase 3

Parkinson's Disease

Novartis Seasonal Influenza Vaccine

Phase 3

Influenza, Human

Meningococcal (Groups A, C, Y and W-135) Conjugate

Phase 3

Meningitis

valsartan plus hydrochlorothiazide

Phase 3

Hypertension

fluvastatin, ezetimibe

Phase 3

Dyslipidemia

Meningococcal C oligosaccharide conjugated vaccine

Phase 3

Meningococcal Disease

gallium (68Ga) gozetotide

Phase 3

Oligometastatic Prostate Cancer (OMPC)

Pneumococcal 7-valent Conjugate Vaccine

Phase 3

Meningitis, Meningococcal

Non-adjuvanted trivalent subunit influenza vaccine (TIV)

Phase 3

Influenza

Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)

Phase 3

Influenza Virus

DTaP

Phase 3

Meningitis, Meningococcal

Hiberix (Haemophilus influenzae type b (Hib) vaccine)

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

Japanese Encephalitis Vaccine

Phase 3

Meningococcal Disease

Lot B of Influenza virus vaccine

Phase 3

Influenza

Rotavirus

Phase 3

Meningitis, Meningococcal

Bexsero® vaccine (2 doses 1 month apart)

Phase 3

Meningoccocal Disease

Meningococcal polysaccharide A, C, Y and W135 and Menveo

Phase 3

Meningitis

Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed

Phase 3

Meningococcal Disease

Serogroup B meningococcal Vaccine lot 3 (rMenB Lot 3)

Phase 3

Serogroup B Meningococcal Meningitis

Novartis MenACWY Vaccine (56 to 65 Years)

Phase 3

Meningococcal Meningitis

Decortin

Phase 3

Uveitis, Intermediate

Hib

Phase 3

Meningitis, Meningococcal

egg-derived influenza subunit vaccine

Phase 3

Influenza

Serogroup B meningococcal Vaccine lot 2 (rMenB Lot 2)

Phase 3

Serogroup B Meningococcal Meningitis

HAV

Phase 3

Meningitis, Meningococcal

MMR

Phase 3

Meningococcal Meningitis

Egg-derived influenza virus vaccine

Phase 3

Influenza

MenACWY CRM (19 to 55 years)

Phase 3

Meningococcal Meningitis

MMR-V

Phase 3

Meningitis, Meningococcal

Gleevec

Phase 3

Leukemia, Myeloid

piflufolastat (18F)

Phase 3

Oligometastatic Prostate Cancer (OMPC)

Lot C of Influenza virus vaccine

Phase 3

Influenza

All 3 consecutive lots of influenza virus vaccine pooled

Phase 3

Influenza

zoledronic acid (aclasta)

Phase 3

Avascular Necrosis of Femoral Head

acid mycophenolic (Myfortic)

Phase 3

Nephrotic Syndrome

anthracycline ((daunorubicin or idarubicin): Induction Phase only

Phase 3

Acute Myeloid Leukemia

Fluticasone/salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

Aflibercept

Phase 3

Neovascular Age-related Macular Degeneration

androgen deprivation therapy

Phase 3

Metastatic Cancer

Mometasone furoate/formoterol (MF/F) combination

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Zometa

Phase 3

Breast Cancer

Calcineurin inhibitors maintenance

Phase 3

Autosomal Dominant Polycystic Kidney Disease

Androgen Receptor Signalling Inhibitor (ARPI)

Phase 3

Prostate Cancer Metastatic

Abelacimab

Phase 3

Atrial Fibrillation (AF)

Nilotinib (Tasigna ®)

Phase 3

Chronic Myeloid Leukemia

GP2017 (adalimumab biosimilar)

Phase 3

Ankylosing Spondylitis

Imatinib Mesylate (Gleevec)

Phase 3

Idiopathic Pulmonary Fibrosis

cyclosporin + mycophenolate mofetil

Phase 3

Kidney Failure

Peg-alpha interferon (Peg-Intron)

Phase 3

Leukemia, Myeloid, Chronic

lisinopril

Phase 3

Hypertension

Benazepril plus hydrochlorothiazide

Phase 3

Hypertension

[68Ga]Ga-PSMA-11

Phase 3

Prostatic Neoplasms

Calcium and vitamin D supplements

Phase 3

Paget's Disease of Bone

Vemurafenib

Phase 3

Melanoma

Chemotherapy

Phase 3

Acute Myeloid Leukemia (AML)

Mycophenolic Acid

Phase 3

Kidney Transplantation

Pelacarsen

Phase 3

Hyperlipoproteinemia (a)

BKM120

Phase 3

PI3K Pathway Activated Tumors

Eltrombopag Tablets

Phase 3

Purpura, Thrombocytopenic, Idiopathic

MenACWY-CRM197 (one dose)

Phase 3

Meningococcal Meningitis

Salbutamol/albuterol

Phase 3

Chronic Obstructive Pulmonary Disease

LOU064 (b.i.d) as a tablet

Phase 3

Chronic Spontaneous Urticaria

PCV7

Phase 3

Meningococcal Meningitis

PCV

Phase 3

Meningococcal Disease

Dexmethylphenidate

Phase 3

Attention Deficit Hyperactivity Disorder

DTPa-IPV-HepB-Hib

Phase 3

Meningococcal Meningitis

Dabrafenib

Phase 3

Melanoma

HBV

Phase 3

Meningococcal Disease

VAY736

Phase 3

Primary Sjogren Syndrome

Teriflunomide capsule

Phase 3

Relapsing Multiple Scelrosis

Tobramycin inhalation powder

Phase 3

Pseudomonas Aeruginosa

TIV

Phase 3

Seasonal Influenza

Pertuzumab

Phase 3

Advanced HER2+Breast Cancer

AIN457 i.v

Phase 3

Psoriatic Arthritis

Pelabresib

Phase 3

Hematologic Malignancy

Midostaurin

Phase 3

FLT3-mutated Acute Myeloid Leukemia

Methylphenidate hydrochloride

Phase 3

ADHD

Unfractionated Heparin

Phase 3

Thromboembolism

Cell culture derived influenza vaccine

Phase 3

Influenza

Rabies

Phase 3

Rabies

RAD001

Phase 3

Metastatic Renal Cell Carcinoma

Relaxin

Phase 3

Heart Failure, Congestive

Antiepileptic drug (1 to 3 only)

Phase 3

Tuberous Sclerosis Complex-associated Refractory Seizures

Taxotere

Phase 3

Non Small Cell Lung Carcinoma

Mammalian cell based flu vaccine

Phase 3

Influenza

Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1)

Phase 3

Serogroup B Meningococcal Meningitis

Combined inactivated hepatitis A & recombinant hepatitis B

Phase 3

Meningococcal Disease

Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29)

Phase 3

Influenza

secukinumab low dose

Phase 3

Moderate to Severe Chronic Plaque-type Psoriasis

Lanzoprazole

Phase 3

Heartburn

Bosentan

Phase 3

Pulmonary Arterial Hypertension

Famciclovir

Phase 3

Genital Herpes

Crizanlizumab (SEG101)

Phase 3

Sickle Cell Disease (SCD)

VAL489

Phase 3

Pediatric Hypertension With or Without CKD

MMF

Phase 3

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Midodrine, albumin, octreotide LAR

Phase 3

Type 2 Hepatorenal Syndrome

Growth Hormone

Phase 3

Idiopathic Short Stature

Pimecrolimus

Phase 3

Atopic Dermatitis

INC424

Phase 3

Myelofibrosis

valsartan + amlodipine

Phase 3

Hypertension

Rivastigmine

Phase 3

Vascular Dementia

Monovalent inactivated influenza vaccine

Phase 3

Pre-pandemic Influenza Vaccine

Ribociclib

Phase 3

Early Breast Cancer

Gliclazide

Phase 3

Diabetes Mellitus, Type 2

Ligelizumab

Phase 3

Chronic Spontaneous Urticaria

QVM149 150/50/160

Phase 3

Asthma

Tacrolimus (tacrolimus elimination)

Phase 3

Liver Transplantation

Ciprofloxacin DPI (BAYQ3939)

Phase 3

Bronchiectasis

LCZ696 (sacubitril/valsartan)

Phase 3

Acute Myocardial Infarction

Mycophenolate mofetil (MMF)

Phase 3

Kidney Transplantation

Pasireotide sub-cutaneous

Phase 3

Cushing's Disease

Nilotinib (AMN107)

Phase 3

Gastrointestinal Stromal Tumor (GIST)

Fluticasone

Phase 3

Asthma

VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE

Phase 3

Hypertension

Mycophenolatmofetil

Phase 3

Lung Transplantation

TIVc_LOT C

Phase 3

Prophylaxis: Influenza

177Lu-PMSA-617

Phase 3

Prostate Cancer Metastatic

Ramipril

Phase 3

Hypertension

Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ

Phase 3

Essential Hypertension

Background lipid lowering therapy

Phase 3

Atherosclerotic Cardiovascular Disease

QVM149

Phase 3

Asthma

2 doses of Meningococcal (group B) multicomponent recombinant adsorbed vaccine

Phase 3

Meningococcal Disease

Valsartan + HCTZ

Phase 3

Hypertension

deferoxamine

Phase 3

Beta-Thalassemia

Inclisiran sodium (equivalent to inclisiran) in

Phase 3

Primary Prevention of Atherosclerotic Cardiovascular Disease

LOU064 (blinded)

Phase 3

Chronic Spontaneous Urticaria

KLU156

Phase 3

Uncomplicated Plasmodium Falciparum Malaria

thiazolidinedione (TZD)

Phase 3

Diabetes Mellitus, Type 2

ARPI

Phase 3

Prostate Cancer

tobramycin

Phase 3

Pseudomonas Infections

inactivated split influenza vaccine

Phase 3

Seasonal Influenza

Secukinumab high dose

Phase 3

Chronic Severe Plaque-type Psoriasis

LOU064 (open label)

Phase 3

Chronic Spontaneous Urticaria

Dexamethasone implant and sham injections

Phase 3

Visual Impairment

TIVc_LOT B

Phase 3

Prophylaxis: Influenza

two doses of rMenB+OMV NZ

Phase 3

Meningococcal Disease

Conventional Therapy

Phase 2

Non-infectious Intermediate Uveitis

Everolimus and Intravesical Gemcitabine

Phase 2

Bladder Cancer

PKN605

Phase 2

Atrial Fibrillation

MIJ821

Phase 2

Depressive Disorder, Treatment-Resistant

SoC (Coartem)

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Evolocumab

Phase 2

Atherosclerotic Cardiovascular Disease

Dovitinib and docetaxel

Phase 2

Gastric Cancer

dabrafenib/trametinib

Phase 2

Anaplastic Thyroid Cancer

QAU145

Phase 2

Cystic Fibrosis

GSK2110183 (afuresertib)

Phase 2

Cancer

Octreotide (Immediate release)

Phase 2

Peritoneal Neoplasms

TMZ

Phase 2

Medulloblastoma

QAV680

Phase 2

Seasonal Allergic Rhinitis

Midostaurin (PKC412)

Phase 2

Leukemia

VAK694; Alutard Avanz SQ

Phase 2

Seasonal Allergic Rhinitis

TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)

Phase 2

Parkinson's Disease

Rapcabtagene autoleucel single agent

Phase 2

Chronic Lymphocytic Leukemia

BION-1301 Single Dose

Phase 2

IgA Nephropathy

RFB002

Phase 2

Diabetic Macular Edema

Men ACWY CRM

Phase 2

Meningococcal Disease

MenACWY-TT

Phase 2

Meningococcal Disease

RKI983A

Phase 2

Glaucoma

QBX258

Phase 2

Asthma

Sandostatin LAR Depot

Phase 2

Primary Insulin Hypersecretion

AF056

Phase 2

Fragile X Syndrome

Treosulfane

Phase 2

Prostate Cancer

Varicella

Phase 2

Meningococcal Meningitis

inhaled corticosteroid therapy

Phase 2

Bronchial Asthma

[177Lu]Lu-DOTA-TATE

Phase 2

Extensive Stage Small Cell Lung Cancer

Lumefantrine Solid Dispersion Formulation

Phase 2

Acute Uncomplicated Plasmodium Falciparum Malaria

Vinorebine, Everolimus

Phase 2

Her2-negative Metastatic Breast Cancer

Daunorubicin or idarubicin

Phase 2

FLT3-mutated Acute Myeloid Leukemia

Indacaterol acetate

Phase 2

Asthma

Aggripal®

Phase 2

Human Influenza

MenACWY polysaccharide vaccine

Phase 2

Meningococcal Meningitis

TOUR006

Phase 2

Thyroid Eye Disease

Iloperidone crystalline formulation

Phase 2

Schizophrenia

telbivudine plus tenofovir disproxil fumarate

Phase 2

Chronic Hepatitis B

Ribociclib plus letrozole

Phase 2

Breast Neoplasms

Miracle Mouthwash Plus Hydrocortisone

Phase 2

Stomatitis

GXV813

Phase 2

Schizophrenia

CNP520

Phase 2

Alzheimer's Disease

hATG

Phase 2

Aplastic Anemia

QGE031

Phase 2

Allergic Asthma

Meningococcal (group B) multicomponent recombinant adsorbed vaccine, without Outer Membrane Vesicles (OMV)

Phase 2

Meningococcal Disease

Mometasone furoate/formoterol fumarate (MFF)

Phase 2

Asthma

Adjuvant endocrine therapy

Phase 2

Breast Cancer

JSB462

Phase 2

Prostatic Cancer, Castration-Resistant

3 weeks Dose Induction of Everolimus

Phase 2

Breast Cancer

LDE225

Phase 2

Basal Cell Carcinoma

LTP

Phase 2

Healthy Volunteers, Pulmonary Arterial Hypertension

ITU512

Phase 2

Sickle Cell Disease

BYM338 active drug

Phase 2

Cachexia

Pasireotide (SOM230), Octreotide (Sandostatin)

Phase 2

Acromegaly

LDK378

Phase 2

Non-Small Cell Lung Cancer

Elidel

Phase 2

Seborrheic Dermatitis

Deferasirox dispersable tablet (DT)

Phase 2

Transfusion-dependent Thalassemia

Aliskiren 3.125 mini-tablets

Phase 2

Hypertension

AQW051

Phase 2

Dyskinesias

indacaterol maleate (LB)

Phase 2

Asthma

Ruxolitinib continuous therapy

Phase 2

Bone Marrow Fibrosis

KAF156

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Meningococcal B vaccine

Phase 2

Meningococcal Meningitis

DYP688

Phase 2

Metastatic Uveal Melanoma

CFZ533 - Cohort 1/Cohort 2

Phase 2

Kidney Transplantation

BGG492A

Phase 2

Chronic Subjective Tinnitus

BVS857

Phase 2

Spinal and Bulbar Muscular Atrophy

LJN452

Phase 2

Primary Bile Acid Diarrhea

Influenza Vaccine, Formulation 2008-2009

Phase 2

Seasonal Influenza

LHW090

Phase 2

Patients, Resistant Hypertension

QMF149 Twisthaler®

Phase 2

Asthma

rMenB

Phase 2

Meningococcal Disease

NIC002

Phase 2

Smokers

Corticosteroids (CS)

Phase 2

Kidney Transplantation

MCS110

Phase 2

Pigmented Villonodular Synovitis

Three doses of Rabies vaccine and two JE vaccine

Phase 2

Rabies

LCI699

Phase 2

Hypertension

QAX028

Phase 2

Chronic Obstructive Pulmonary Disease

Maintenance population: MMF

Phase 2

Kidney Transplantation

CGF166

Phase 2

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

RAD001, Letrozole

Phase 2

Breast Neoplasm

IV Artesunate

Phase 2

Severe Malaria

MF59 adjuvanted H5N1 influenza vaccine

Phase 2

Influenza

EYU688

Phase 2

Dengue

Aliskiren/Valsartan

Phase 2

Hypertension

MAS825

Phase 2

COVID-19 Pneumonia, Impaired Respiratory Function

Tulmimetostat DL1 QD

Phase 2

Progressive Metastatic Castrate Resistant Prostate Cancer

RAD001 (Everolimus)

Phase 2

Systemic Mastocytosis

FGF401

Phase 2

Hepatocellular Carcinoma (HCC)

QBW251

Phase 2

Pulmonary Disease, Chronic Obstructive

BYM338

Phase 2

Skeletal Muscle

Nilotinib (Tasigna)

Phase 2

Systemic Sclerosis

DII235

Phase 2

Lipoprotein Disorder

Asciminib add-on

Phase 2

CML

LEZ763

Phase 2

Type II Diabetes

ECF843

Phase 2

Dry Eye

LBH589 (panobinostat)

Phase 2

Relapse/Refractory Multiple Myeloma

TK1258

Phase 2

Prostate Cancer

PTK787/ZK222584

Phase 2

Multiple Myeloma

tenofovir disproxil fumarate

Phase 2

Chronic Hepatitis B

Application of pimecrolimus

Phase 2

Vitiligo Vulgaris

cyclosporine (reduced exposure)/everolimus

Phase 2

Kidney Transplantation

EGF816

Phase 2

Advanced Non-small Cell Lung Cancer

Dabrafenib Mesylate

Phase 2

Hematopoietic and Lymphoid Cell Neoplasm

AEE788

Phase 2

Brain and Central Nervous System Tumors

GBS trivalent vaccine

Phase 2

GBS Disease

MenACWY-CRM197

Phase 2

Meningococcal Disease

GIA632

Phase 2

Atopic Dermatitis

Nilotinib, Pegylated interferon alpha-2b, Imatinib

Phase 2

Chronic Myeloid Leukaemia

CPK850

Phase 2

Retinitis Pigmentosa

BAF312 solution

Phase 2

Hemorrhagic Stroke

Indacaterol via the Concept1 dry-powder inhaler

Phase 2

Asthma

tamoxifen citrate

Phase 2

Breast Cancer

Investigator choice of chemotherapy

Phase 2

Nasopharyngeal Carcinoma

NZ MenB OMV vaccine (NZ98/254)

Phase 2

Meningococcal Infections

QBW276

Phase 2

Pulmonary Cystic Fibrosis

short acting β2- agonist

Phase 2

COPD

Nidufexor

Phase 2

Diabetic Nephropathy

Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

everolimus + low-dose tacrolimus

Phase 2

Highly-sensitized Kidney Transplant Recipients

Sample collection

Phase 2

Squamous Cell Anal Carcinoma

DDY391

Phase 2

Moderate to Severe Psoriatic Arthritis

fluticasone propionate/salmeterol

Phase 2

Asthma

Irinotecan associated to fluorouracil and leucovorin

Phase 2

Gastric Cancer

SOM230

Phase 2

Dumping Syndrome

Intravitreal ranibizumab with photodynamic therapy

Phase 2

Age Related Macular Degeneration

HCD122

Phase 2

Non-Hodgkin's Lymphoma

valtorcitabine

Phase 2

Hepatitis B

meningococcal B vaccine & meningococcal ACYW conjugate vaccine

Phase 2

Meningococcal Meningitis, Serogroup A

PC7

Phase 2

Meningococcal Meningitis

Secukinmab

Phase 2

Rheumatoid Arthritis

ARPI: Abiraterone

Phase 2

Metastatic Castration Resistant Prostate Cancer (mCRPC)

LNA043

Phase 2

Osteoarthritis

LOU064 Arm 1

Phase 2

Chronic Spontaneous Urticaria

RAD001(everolimus)

Phase 2

Carcinoma

4CMenB

Phase 2

Meningococcal Disease

LFF571

Phase 2

Moderate Clostridium Difficile Infection

68Ga-FAP-2286

Phase 2

Solid Tumor

225Ac-PSMA-R2

Phase 2

Prostate Cancer

Imatinib mesylate and panitumumab

Phase 2

Colorectal Neoplasm

LFG316

Phase 2

Paroxysmal Nocturnal Hemoglobinuria

68Ga-DOTA-MGS5

Phase 2

Neuroendocrine Tumors

Oral dabrafenib and trametinib

Phase 2

Craniopharyngioma

Sevelamer HCl

Phase 2

Chronic Kidney Disease

Seasonal Influenza Vaccine (MF59C.1)

Phase 2

Seasonal Influenza

FWY003

Phase 2

Geographic Atrophy Secondary to Age-related Macular Degeneration

LLG783

Phase 2

Peripheral Artery Disease (PAD); Intermittent Claudication

KRP203

Phase 2

Subacute Cutaneous Lupus Erythematosus

Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)

Phase 2

Hormone Receptor Positive Breast Cancer

Crizanlizuamb

Phase 2

Sickle Cell Disease (SCD)

Smac Mimetic LCL161

Phase 2

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Alum

Phase 2

Alzheimer's Disease

Panobinostat/LBH589

Phase 2

Refractory Leukemia

Pneumococcal vaccine

Phase 2

Meningococcal Infections

Zotatifin

Phase 2

Breast Cancer

MIJ821 Subcutaneous

Phase 2

Treatment-Resistant Depression

gemcitabine and nab paclitaxel

Phase 2

Pancreatic Cancer

Montelukast

Phase 2

Allergic Rhinitis

TIP

Phase 2

Non-cystic Fibrosis Bronchiectasis

Meningococcal B vaccine with antipyretic

Phase 2

Meningococcal Meningitis

Fenofibrate

Phase 2

Non Familial Chylocmicronemia Syndrome (Non-FCS)

Seasonal flu vaccine

Phase 2

Seasonal Influenza

BGJ398

Phase 2

Recurrent Glioblastoma or Other Glioma Subtypes

Alpelisib (BYL719)

Phase 2

Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)

GHZ339

Phase 2

Atopic Dermatitis

LYS006

Phase 2

Hidradenitis Suppurativa

[177Lu]Lu-PSMA-617

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Cryptosporidium parvum oocysts (ABO809)

Phase 2

Cryptosporidiosis

Letrozole OR Anastrozole

Phase 2

Breast Cancer

LFG316 Lower dose

Phase 2

Geographic Atrophy

thrombopoietin receptor agonist (TPO-RA)

Phase 2

Primary Immune Thrombocytopenia (ITP)

Dovitinib (TKI258)

Phase 2

Tumor Pathway Activations Inhibited by Dovitinib

EPO906 epothilone B

Phase 2

Carcinoid

Autologous Tumor Cell-Based Vaccine

Phase 2

Lymphoma

sacubitril/valsartan (LCZ696)

Phase 2

Hypertension

sabatolimab

Phase 2

Myelodysplastic Syndromes

LEE-011

Phase 2

Metastatic Breast Cancer

Glucocorticoids

Phase 2

ANCA Associated Vasculitis (AAV)

AIN 457

Phase 2

Non-infectious Uveitis

Eltrombopag (Revolade®)

Phase 2

Primary Immune Thrombocytopenia (ITP)

Lutetium Lu 177 Vipivotide Tetraxetan

Phase 2

Prostate Carcinoma

EBRT + 6 mo ADT + 177Lu-PSMA-617

Phase 2

High-Risk Localized Prostate Cancer

CJM112

Phase 2

Hidradenitis Suppurativa (Acne Inversa)

XXB750 drug

Phase 2

Resistant Hypertension

Bicalutamide

Phase 2

Triple Negative Breast Cancer

XBD173

Phase 2

Anxiety Disorders

Calcium carbonate/magnesium hydroxide/Lansoprazole

Phase 2

Heartburn

LBH581

Phase 2

Small Cell Lung Carcinoma

5-azacytidine

Phase 2

Leukemia

INE963

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

KAE609 (Cipargamin)

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Endocrine Therapy

Phase 2

Breast Cancer

Entacapone

Phase 2

Parkinson's Disease

CFZ533 - MMF - CS

Phase 2

Kidney Transplant Rejection

LCZ696A

Phase 2

Pharmacokinetics

alb-interferon alfa 2b

Phase 2

Chronic Hepatitis C

Tacrolimus (Tac)

Phase 2

Kidney Transplantation

STI571

Phase 2

Systemic Sclerosis, Scleroderma

CFZ533

Phase 2

Lupus Nephritis

Indacaterol 37.5

Phase 2

Asthma

Kenalog

Phase 2

Age-Related Macular Degeneration

Induction therapy: basiliximab

Phase 2

Kidney Transplantation

Panobinostat (LBH589)

Phase 2

Myelodysplastic Syndromes

RHH646

Phase 2

Osteoarthritis, Knee

Serelaxin

Phase 2

Labor, Induced

Rapcabtagene autoleucel

Phase 2

Idiopathic Inflammatory Myopathies

N-acetylcysteine

Phase 2

Common Cold Associated With Cough

high-dose imatinib

Phase 2

CML

sotrastaurin + tacrolimus + standard of care medications

Phase 2

Liver Transplantation

MMR (Measles, Mumps and Rubella vaccine)

Phase 2

Prevention of Meningococcal Disease

AMN107- NILOTINIB

Phase 2

Gastrointestinal Stromal Tumors (GIST)

Sumatriptan

Phase 2

Migraine

Oxybutynin

Phase 2

Healthy Volunteers

H5N1 Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza

Canakinumab Injection

Phase 2

Myelodysplastic Syndromes

CLAG Regimen

Phase 2

Leukemia

Gleevec™

Phase 2

Lung Cancer

DTaPHibIPV (Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine)

Phase 2

Prevention of Meningococcal Disease

DTaP-Hib-IPV

Phase 2

Meningococcal Disease

Buparlisib (BKM120)

Phase 2

Lymphoma

QAV680 + Cetirizine

Phase 2

Allergic Rhinitis

AHU377

Phase 2

Hypertension

EPO906

Phase 2

Colon Cancer

Influenza vaccine surface antigen adjuvanted with MF59

Phase 2

Pandemic Influenza Disease

Investigational new drug, company code: BGG492

Phase 2

Partial Onset Seizures

Sonidegib

Phase 2

Recurrent Plasma Cell Myeloma

RLX030 (serelaxin)

Phase 2

Chronic Heart Failure

MenACWY PS (MenACWY-CRM, polysaccharide vaccine)

Phase 2

Prevention of Meningococcal Disease

AEB071/everolimus

Phase 2

Kidney Transplantation

Surface Antigen, Inactivated (Adjuvanted with MF59C.1), form. 2006-07

Phase 2

Influenza

VAY736 PFS

Phase 2

Sjögrens Disease

NIC002 in Aluminum hydroxide (Alum)

Phase 2

Nicotine Dependence

indacaterol/glycopyrrolate

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

QAW039 capsules once daily

Phase 2

Persistent Asthma

Menjugate (Men C conjugated vaccine)

Phase 2

Prevention of Meningococcal Disease

MenC-Hib

Phase 2

Healthy

Asciminib single agent

Phase 2

Chronic Myelogenous Leukemia

Intravitreal injection ranibizumab

Phase 2

Type 2 Idiopathic Macular Telangiectasia

Pasireotide LAR and Everolimus Combination

Phase 2

Neuroendocrine Carcinoma of the Lung and Thymus

BFH772

Phase 2

Psoriasis

INC280

Phase 2

Non-small Cell Lung Cancer

Deferasirox granule formulation

Phase 2

Transfusion-dependent Anemia

Naproxen

Phase 2

Osteoarthritis

Deferasirox dispersible tablet

Phase 2

Chronic Iron Overload Due to Transfusion-dependant Anemias

Daunorubicin

Phase 2

Acute Leukaemia

GBS Vaccine

Phase 2

Infections, Streptococcal

Prevnar (pneumococcal polysaccharide serotypes 4, 9V, 14, 18C, 19F, 23F & 6B conjugated to the CRM197)

Phase 2

Prevention of Meningococcal Disease

AMO959

Phase 2

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Tropifexor (LJN452)

Phase 2

Non-alcoholic Steatohepatitis (NASH)

MenACWY Ad+ (MenACWY-CRM, adjuvanted formulation)

Phase 2

Prevention of Meningococcal Disease

Opnurasib

Phase 2

Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer

HBV (Hepatitis B vaccine)

Phase 2

Prevention of Meningococcal Disease

MenC-CRM ROS

Phase 2

Meningococcal Disease

VHB937

Phase 2

Amyotrophic Lateral Sclerosis (ALS)

MenACWY-CRM conjugate vaccine, unadjuvanted

Phase 2

Prevention of Meningococcal Disease

Iscalimab

Phase 2

Sjogren's Syndrome

Group B Streptococcus Trivalent Vaccine

Phase 2

Streptococcal Infection

Trivalent influenza vaccine (TIVc)

Phase 2

Influenza

LXE408

Phase 2

Chagas Disease

Aflunov (Single prime, single boost)

Phase 2

Influenza

BYL-719 (alpelisib)

Phase 2

Breast Cancer

Influenza Trivalent Inactivated Vaccines

Phase 2

FLU

Tivozanib

Phase 2

Gastrointestinal Cancer

High Dose Methylprednisolone (HDMP)

Phase 2

Chronic Lymphocytic Leukemia

SPP100

Phase 2

Hypertension

PTK787

Phase 2

Wet Age-Related Macular Degeneration

Deferoxamine (DFO)

Phase 2

Sickle Cell Disease

hATG, CsA, EPAG Day 14 to Month 6

Phase 2

Severe Aplastic Anemia

SOM230 s.c

Phase 2

Cushing's Syndrome

LBH589

Phase 2

Lymphoma

Asciminib Pediatric formulation group

Phase 2

Myeloid Leukemia, Philadelphia Positive

Adjuvanted H5N1 pandemic influenza vaccine

Phase 2

Pandemic H5N1 Influenza

ACZ885 (investigational)

Phase 2

Rheumatoid Arthritis

PDR001, Imatinib

Phase 2

Gastrointestinal Stromal Tumors

CFZ533 active - Cohort 1

Phase 2

Primary Sjögren's Syndrome

ARV-766 Part A&B

Phase 2

Prostate Cancer Metastatic

TNO155

Phase 2

KRAS G12C Mutant Solid Tumors

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine

Phase 2

Meningococcal Disease

MenABCWY

Phase 2

Meningococcal Disease

Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009

Phase 2

Influenza

NGI226

Phase 2

Achilles Tendinopathy

Alpelisib Pill

Phase 2

Endometroid Endometrial Cancer

Deferasirox film coated tablet (FCT)

Phase 2

Transfusion-dependent Thalassemia

Itraconazole

Phase 2

Acute Myeloid Leukemia

AEB071

Phase 2

Uveitis

Surface Antigen, Inactivated, Influenza (form.2006-07)

Phase 2

Influenza

Core Study: Deferasirox

Phase 2

Transfusional Iron Overload

LUM-SDF

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Octreotide Depot

Phase 2

Neuroendocrine Carcinoma

BGG492

Phase 2

Photosensitive Epilepsy

Group B streptococcus vaccine

Phase 2

Streptococcal Infections

AQW051 (single and multiple doses)

Phase 2

Schizophrenia Disorders

AIN457A

Phase 2

Ankylosing Spondylitis

Novartis Meningococcal (MenACWY-CRM) vaccine

Phase 2

Meningococcal Disease

ECI830

Phase 2

Advanced HR+/HER2- Breast Cancer

MenC-CRM

Phase 2

Meningococcal Meningitis

MenABCWY+¼OMV

Phase 2

Meningococcal Disease

QCZ484

Phase 2

Hypercholesterolaemia

AFQ056

Phase 2

Parkinson's Disease

Extended Release Methylphenidate (Ritalin LA) plus Behavior Therapy

Phase 2

Attention Deficit Hyperactivity Disorder

DJI136

Phase 2

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Abraxane

Phase 2

Breast Cancer

Zometa (zoledronic acid)

Phase 2

Nasopharyngeal Cancer

MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation)

Phase 2

Prevention of Meningococcal Disease

Patupilone

Phase 2

Metastatic Hormone Refractory Prostate Cancer

Lu-PSMA-617

Phase 2

Liver Cancer

branaplam

Phase 2

Spinal Muscular Atrophy

rapcabtagene autoleucel (YTB323)

Phase 2

Progressive Multiple Sclerosis

Everolimus (Afinitor®)

Phase 2

Poorly Differentiated Malignant Neuroendocrine Carcinoma

RAD001 (Everolimus) and Pasireotide (SOM230) LAR

Phase 2

Uveal Melanoma

Panitumumab

Phase 2

Cancer

HSC835

Phase 2

Acute Myelocytic Leukemia

Ofatumumab with GSK2110183

Phase 2

Chronic Lymphocytic Leukemia (CLL)

Atrasentan

Phase 2

IgA Nephropathy

PDR001

Phase 2

Melanoma

QAX576

Phase 2

Asthma

PTC518

Phase 2

Huntington Disease

Vi Polysaccharide (PS) vaccine

Phase 2

Typhoid Fever

LIK066

Phase 2

Elevated Body Mass Index

Visudyne

Phase 2

Age-Related Macular Degeneration

Influenza Trivalent Inactivated vaccines Novartis

Phase 2

Influenza

Adjuvanted Trivalent Influenza Virus Vaccine (aTIV)

Phase 2

Human Influenza

TKI258

Phase 2

Solid Tumors and Advanced Endometrial Cancer

YTB323

Phase 2

Systemic Lupus Erythematosus

Lapatinib/nab-Paclitaxel

Phase 2

Neoplasms, Breast

BHQ880

Phase 2

Smoldering Multiple Myeloma

DNK333

Phase 2

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Buparlisib

Phase 2

Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

QVM149 o.d

Phase 2

Asthma

Eplerenone

Phase 2

Essential Hypertension

Indacaterol (QAB149)

Phase 2

COPD

Maintenance population: EC-MPS

Phase 2

Kidney Transplantation

G-CSF

Phase 2

Leukemia

Imatinib Mesylate and Nilotinib

Phase 2

Graft Versus Host Disease

Bridging Therapy

Phase 2

Non-Hodgkin Lymphoma

balicatib (AAE581)

Phase 2

Knee Osteoarthritis

Nazartinib

Phase 2

Advanced Solid Tumors Which Are cMET-dependent

LRX712

Phase 2

Osteoarthritis (OA)

TIN816 lyophilisate powder

Phase 2

Acute Kidney Injury Due to Sepsis

LAG525

Phase 2

Triple-negative Breast Cancer

Deferasirox DFX, DT

Phase 2

Low and Int 1-risk Myelodysplastic Syndrome

Iptacopan (part 1)

Phase 2

Lupus Nephritis

MF59-eH5N1

Phase 2

Pandemic

UNR844-Cl

Phase 2

Presbyopia

DTIC

Phase 2

Melanoma

Rabbit ATG

Phase 2

Aplastic Anemia

APL180

Phase 2

Coronary Heart Disease

CSJ148

Phase 2

HCMV

Pazopanib plus Gemcitabine

Phase 2

Leiomyosarcoma or Carcinosarcoma

SAF312

Phase 2

Postoperative Ocular Pain After PRK Surgery

Zoledronic Acid; Letrozole

Phase 2

Breast Cancer

BAT

Phase 2

Polycythemia Vera (PV)

Gleevec and Taxotere

Phase 2

Lung Cancer

epothilone b

Phase 2

Ovarian Neoplasms

PTK787/ZK 222584

Phase 2

Von Hippel-Lindau Disease

CSJ117

Phase 2

Pulmonary Disease, Chronic Obstructive

Deferasirox and Deferoxamine

Phase 2

Cardiac Iron Overload

Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV

Phase 2

Invasive Meningococcal Disease

Fluad H5N1 Pandemic Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza Vaccine

indacaterol maleate/mometasone furoate

Phase 2

Asthma

Imatinib (Glevec is the brand name for imatinib)

Phase 2

Gastrointestinal Stromal Tumors

Pazopanib Hydrochloride

Phase 2

Adult Alveolar Soft Part Sarcoma

Votoplam

Phase 2

Huntington Disease

MEK162

Phase 2

Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma

combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus influenzae B vaccine

Phase 2

Meningococcal Infections

Mesna

Phase 2

Leukemia

BEZ235 (Stage 1)

Phase 2

Pancreatic Neuroendocrine Tumors (pNET)

Surface antigen inactivated influenza vaccine

Phase 2

Influenza

Asciminib Adult formulation

Phase 2

Acute Lymphoblastic Leukemia

Meningococcal Vaccine

Phase 2

Meningococcal Disease

Tulmimetostat

Phase 2

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

MenABCWY+OMV

Phase 2

Meningococcal Disease

AFQ056 with L-dopa

Phase 2

Parkinson's Disease

Gemcitabine and Pazopanib

Phase 2

Sarcoma

ICL670, deferoxamine

Phase 2

Anemia, Sickle Cell

PTK787/ZK 222584 (vatalanib)

Phase 2

Tumors

IGE025

Phase 2

Chronic Idiopathic Urticaria

CAD106

Phase 2

Alzheimer Disease

MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO

Phase 2

Acute Myeloid Leukemia

DFV890

Phase 2

Coronary Heart Disease

CMK389

Phase 2

Atopic Dermatitis

Nilotinib followed by treatment-free

Phase 2

Chronic Myelogenous Leukemia

Sacubitril/Valsartan Oral Tablet

Phase 2

Covid19

[68Ga]Ga-NeoB

Phase 2

Breast Cancer

AUY922

Phase 2

Non-small-cell Lung Cancer

LXH254

Phase 2

Melanoma

TCH346

Phase 2

Amyotrophic Lateral Sclerosis

Eltrombopag olamine

Phase 2

Lymphoma

NIM811

Phase 2

Chronic Hepatitis C Genotype-1 Relapse

GVV858

Phase 2

Advanced HR+/HER2- Breast Cancer

SBR759

Phase 2

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

STI571 (Glivec®)

Phase 2

Prostatic Neoplasm

MenC-CRM LIQ

Phase 2

Meningococcal Disease

LEE011

Phase 2

Teratoma

AAE581

Phase 2

Osteoporosis

Simulect®

Phase 2

Renal Transplantation

NVGH Vi-CRM197

Phase 2

Typhoid Fever

MenACWY-CRM conjugate vaccine, adjuvanted

Phase 2

Prevention of Meningococcal Disease

Trivalent subunit inactivated flu vaccine, Formulation 2010-2011

Phase 2

Seasonal Influenza

VAK694

Phase 2

Allergic Rhinitis

Topotecan hydrochloride

Phase 2

Neuroblastoma

BYL719

Phase 2

Breast Cancer

Pandemic influenza vaccine + seasonal influenza vaccine/pandemic influenza vaccine

Phase 2

Influenza

Medroxyprogesterone Acetate

Phase 2

Advanced, Persistent, or Recurrent Endometrial Cancer

Coartem

Phase 2

Acute Uncomplicated Plasmodium Falciparum Malaria

[177Lu]Lu-DOTATATE

Phase 2

Intracranial Meningioma

aTIV

Phase 2

Human Influenza

BGT226

Phase 2

Solid Tumors

Induction therapy: rabbit anti-thymocyte globulin (rATG)

Phase 2

Kidney Transplantation

Cyclosporine A

Phase 2

Atopic Dermatitis

LCQ908A

Phase 2

Type 2 Diabetes Mellitus

LKA651

Phase 2

Diabetic Macular Edema

Imatinib (Gleevec)

Phase 2

Metastatic Melanoma

CTL019 T-cells

Phase 2

B-cell Acute Lymphoblastic Leukemia

Deferasirox (ICL670)

Phase 2

Chronic Anemia

MF59C.1-adjuvanted subunit influenza vaccine

Phase 2

Seasonal Influenza

sodium stibogluconate

Phase 2

Primary Visceral Leishmaniasis

Dexamethasone based mouthwash

Phase 2

Advanced Breast Cancer

SMC021

Phase 2

Health Postmenopausal Women

AAA517

Phase 2

Prostatic Neoplasm

KAE609

Phase 2

Malaria

Vi-CRM197 vaccine

Phase 2

Typhoid Fever

Terlipressin acetate

Phase 2

Compensated Cirrhosis and Portal Hypertension

Infliximab

Phase 2

Crohn's Disease

SAF312A

Phase 2

Postoperative Pain

ECMPS-IEM

Phase 2

Detection Accuracy

verteporfin

Phase 2

Macular Degeneration

Two doses of Rabies vaccine and two JE vaccine

Phase 2

Rabies

Canakinumab (investigational)

Phase 2

Rheumatoid Arthritis

RAF265

Phase 2

Metastatic Melanoma

mometasone furoate

Phase 2

Asthma

AD 237

Phase 2

COPD

GSK2118436

Phase 2

Cancer

Cipargamin

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

BZF961

Phase 2

Hepatitis C

NSAI: Letrozole or Anastrazole

Phase 2

Breast Cancer

ABL001/Asciminib

Phase 2

Chronic Myeloid Leukemia (CML)

Investigational Treatment

Phase 2

External Genital Warts

rabbit anti-thymocyte globulin (r-ATG)

Phase 2

Severe Aplastic Anemia (SAA)

CLR325

Phase 2

Chronic Stable Heart Failure

Zoledronate

Phase 2

Kidney Cancer

Actinium Ac 225 Vipivotide Tetraxetan

Phase 2

Oligometastatic Prostate Adenocarcinoma

H5N1 pandemic Influenza vaccine

Phase 2

Pandemic H5N1 Influenza

LCL161

Phase 2

Breast Cancer

Spartalizumab

Phase 2

Carcinoma, Non-Small-Cell Lung

Seasonal Allergic Rhinitis

2 drugs in this indication

IgA Nephropathy

2 drugs in this indication

Hypertension

2 drugs in this indication

Chronic Plaque Type Psoriasis

1 drug in this indication

Peritoneal Neoplasms

1 drug in this indication

Cancer

1 drug in this indication

Persistent Asthma

1 drug in this indication

PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)

1 drug in this indication

Acute Myeloid Leukemia (AML)

1 drug in this indication

Chronic Obstructive Pulmonary Disease (COPD)

1 drug in this indication

cardiovascular disease

1 drug in this indication

elevated Lp(a) and established cardiovascular disease

1 drug in this indication

atherosclerotic cardiovascular disease with elevated lipoprotein(a)

1 drug in this indication

Paget's Disease of Bone

1 drug in this indication

nephrology

1 drug in this indication

primary IgAN

1 drug in this indication

immunoglobulin A nephropathy (IgAN)

1 drug in this indication

Primary IgAN (IgA Nephropathy) to slow decline of kidney function in adults at risk of disease progression

1 drug in this indication

primary immunoglobulin A nephropathy (IgAN)

1 drug in this indication

polymyalgia rheumatica (PMR)

1 drug in this indication

Relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) in pediatric and young adult patients

1 drug in this indication

autoimmune disease, cancer

1 drug in this indication

Hormone Receptor Positive Breast Cancer

1 drug in this indication

Pathological Myopia

1 drug in this indication

immunology

1 drug in this indication

Renal Interstitial Fibrosis

1 drug in this indication

CD3xCD19 T cell engager

1 drug in this indication

autoimmune

1 drug in this indication

CD19xCD3 T-Cell Engager

1 drug in this indication

Non-infectious Intermediate Uveitis

1 drug in this indication

Meningococcal Disease

1 drug in this indication

Prostatic Neoplasms

1 drug in this indication

Medulloblastoma

1 drug in this indication

Leukemia

1 drug in this indication

IgAN

1 drug in this indication

Anaplastic Thyroid Cancer

1 drug in this indication

Gastric Cancer

1 drug in this indication

Uncomplicated Plasmodium Falciparum Malaria

1 drug in this indication

Cystic Fibrosis

1 drug in this indication

Melanoma

1 drug in this indication

Influenza

1 drug in this indication

Polymyalgia rheumatica

1 drug in this indication

lupus nephritis

1 drug in this indication

social anxiety

1 drug in this indication

Multiple sclerosis (relapsing)

1 drug in this indication

HR+/HER2- early breast cancer (adjuvant, in combination with a non-steroidal aromatase inhibitor)

1 drug in this indication

relapsing multiple sclerosis (RMS)

1 drug in this indication

early breast cancer

1 drug in this indication

Relapsing multiple sclerosis

1 drug in this indication

multiple sclerosis

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→

Frequently asked questions

What is in Novartis AG's drug pipeline?→

CatalystAlert tracks 982 drug candidates in Novartis AG's (NVS) pipeline across Phase 3, Phase 2. Its lead program is Alpelisib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Novartis AG's next FDA catalyst?→

Novartis AG's (NVS) next tracked catalyst is a Phase 3 readout expected October 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track NVS biotech catalysts?→

Add NVS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Novartis AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply